<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H68709BC3ED944C7DA18959158E359873" public-private="public"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>110 HR 4844 IH: To suspend temporarily the duty on mixtures containing n-butyl-1,2-ben­zi­so­thi­az­o­lin-3-one (Butyl ben­zi­so­thi­az­o­line technical), 1-hy­droxy­pyr­i­dine-2-thione, zinc salt (Zinc pyrithione) and application adjuvants.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2007-12-19</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form> 
<distribution-code display="yes">I</distribution-code> 
<congress>110th CONGRESS</congress> <session>1st Session</session> 
<legis-num>H. R. 4844</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20071219">December 19, 2007</action-date> 
<action-desc><sponsor name-id="R000569">Mr. Reynolds</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name></action-desc> 
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To suspend temporarily the duty on mixtures containing n-butyl-1,2-ben­zi­so­thi­az­o­lin-3-one (Butyl ben­zi­so­thi­az­o­line technical), 1-hy­droxy­pyr­i­dine-2-thione, zinc salt (Zinc pyrithione) and application adjuvants.</official-title> 
</form> 
<legis-body id="H97E4B282E3B74FFE9345BDF38C691FE8" style="OLC"> 
<section display-inline="no-display-inline" id="HA545CF432D854C3C8280607F5FE0A753" section-type="section-one"><enum>1.</enum><header>Mixtures containing n-butyl-1,2-ben­zi­so­thi­az­o­lin-3-one (Butyl ben­zi­so­thi­az­o­line technical), 1-hy­droxy­pyr­i­dine-2-thi­one, zinc salt (Zinc pyr­i­thi­one) and application adjuvants</header> 
<subsection id="H796B1254E5B0445C876E61AB3C79FED5"><enum>(a)</enum><header>In general</header><text>Subchapter II of chapter 99 of the Harmonized Tariff Schedule of the United States is amended by inserting in numerical sequence the following new heading:</text>
<quoted-block display-inline="no-display-inline" id="H37B6DCD7D9124003896893D03DE20063" style="OLC"> 
<table align-to-level="section" blank-lines-before="1" colsep="1" frame="none" line-rules="hor-ver" rowsep="0" rule-weights="0.0.0.0.4.17" subformat="S6211" table-template-name="Duty Suspension, 8 Column" table-type="exception-quote"> 
<tgroup block-style="1" cols="8" grid-typeface="1.1" rowsep="0" thead-tbody-ldg-size="0.7.9"><colspec coldef="txt-no-ldr-no-spread" colname="column1" colwidth="8pts" min-data-value="8"/><colspec coldef="txt-no-ldr-no-spread" colname="column2" colwidth="48.75pt" min-data-value="35"/><colspec coldef="txt" colname="column3" colwidth="177.00pt" min-data-value="60"/><colspec coldef="txt-no-ldr-no-spread" colname="column4" colwidth="35.25pt" min-data-value="25"/><colspec coldef="txt-no-ldr-no-spread" colname="column5" colwidth="41.25pt" min-data-value="38"/><colspec coldef="txt-no-ldr-no-spread" colname="column6" colwidth="42.00pt" min-data-value="38"/><colspec coldef="txt-no-spread" colname="column7" colwidth="60.50pt" min-data-value="38"/><colspec coldef="fig" colname="column8" colwidth="8.75pt" min-data-value="3"/> 
<tbody> 
<row><entry align="left" colname="column1" leader-modify="clr-ldr" rowsep="0" stub-definition="txt-clr" stub-hierarchy="1"></entry><entry align="left" colname="column2" leader-modify="clr-ldr" rowsep="0" valign="top">9902._._</entry><entry align="left" colname="column3" leader-modify="force-ldr-bottom" rowsep="0" valign="bottom">Mixtures containing n-butyl-1,2-benzisothiazolin-3-one (Butyl benzisothiazoline technical) (CAS No. 4299–07–4), 1-hydroxypyridine-2-thione, zinc salt (Zinc pyrithione) (CAS No. 13463–41–7) and application adjuvants (provided for in subheading 3808.99.08)</entry><entry align="left" colname="column4" leader-modify="clr-ldr" rowsep="0" valign="bottom">Free</entry><entry align="left" colname="column5" leader-modify="clr-ldr" rowsep="0" valign="bottom">No change</entry><entry align="left" colname="column6" leader-modify="clr-ldr" rowsep="0" valign="bottom">No change</entry><entry align="left" colname="column7" leader-modify="force-ldr-bottom" rowsep="0" valign="bottom">On or before 12/31/2011</entry><entry align="right" colname="column8" rowsep="0" valign="bottom"></entry> </row> </tbody> </tgroup></table> <after-quoted-block>.</after-quoted-block></quoted-block> </subsection>
<subsection id="H089E1D4545C9421ABED5ACCBC2EA753"><enum>(b)</enum><header>Effective date</header><text>The amendment made by subsection (a) applies to articles entered, or withdrawn from warehouse for consumption, on or after the 15th day after the date of the enactment of this Act.</text> </subsection></section>
</legis-body> 
</bill> 


